DELIVERING SYSTEM ANTI-CANCER TREATMENT (SACT) IN WESTERN ISLES
|
|
- Adele Bradford
- 6 years ago
- Views:
Transcription
1 NOSCAN Offices Rosehill Annexe ARI Site Cornhill Road Aberdeen AB25 2ZG Tel DELIVERING SYSTEM ANTI-CANCER TREATMENT (SACT) IN WESTERN ISLES Introduction 2 Method 2 Background 3 Service Provision 3 Drivers for change 4 Assessments of the current chemotherapy service 5 The strengths of the current local service: 5 The weaknesses of the current service are: 6 The proposed Road Map 8 General principles 8 Recommendations and issues to consider 8 Threats to the development of a locally delivered chemotherapy 10 Conclusion 10 References 11
2 Introduction Following the publication of the [REVISED] GUIDANCE FOR THE SAFE DELIVERY OF SYSTEMIC ANTI-CANCER THERAPY (SACT) CEL 30 (2012), NOSCAN has supported constituent Health Boards undertaking their first self assessment of Systemic Anti-Cancer Therapy (SACT) services against the standards set out within the CEL. A member of the NOSCAN executive team visited NHS Western Isles (NHS WI) to support its nominated lead cancer professionals in undertaking a baseline audit on the 5 th and 6 th September. During that visit, it was apparent that the SACT service was confronting a number of challenges simultaneously, including the implementation of the CEL. It was therefore agreed that it would be advantageous to review the service as a whole in the context of the drivers for change and to consider the future provision of services to ensure a robust and secure service, able to address the challenges likely to be experienced in the future. NOSCAN offered to support this review. Dr James Ward, Medical Director Executive Lead for Cancer, NHS WI accepted this recommendation and commissioned this piece of work. Method The methodology was to undertake a number of interviews with staff involved in SACT and cancer service provision, followed by a feedback and discussion at a joint session of the cancer team. Key members of staff were identified by Ms Gill Chadwick, Macmillan Lead Cancer Nurse. A scoping visit was undertaken on 4 th and 5 th November. This was led by Mr Mark Parsons (NOSCAN Regional Lead Cancer Pharmacist) with the support of Mrs Fiona Campbell (Macmillan Clinical Nurse Specialist, Oncology/Chemotherapy, NHS Highland). Mr Parsons and Mrs Campbell met with staff for individual or team discussions in a confidential manner using Chatham House rules. Thus, it was agreed that, when appropriate, the content of discussions would be shared but that the identity of speakers would remain in confidence. The SACT service in NHS WI was represented by the following members of staff: Name Role SACT Nurse Dr Jim Ward Medical Director, NHS WI Ms Gill Chadwick Macmillan Lead Cancer Nurse Mr Jimmy Myles Lead Nurse, Western Isles Hospital Mrs Dawn Tiernan Chief Pharmacist, NHS WI Miss Chris Ann MacLean Macmillan Stoma & Colorectal CNS Mr George MacLeod Staff Nurse, Surgical Ward Mrs Fiona Campbell Staff Nurse, Surgical Ward Mrs Donna Parkes Macmillan Nurse Ms Mairi Smith Macmillan Nurse Mrs Linda Macmillan Senior Pharmacy Technician The purpose of the process was to: Discuss and explore the current provision of SACT services for residents on the Western Isles. Engage with key staff (nursing, pharmacy, medical) to discuss potential options and opportunities for the future provision and management of the Systemic Anti-Cancer Therapy (SACT) treatment. Help to articulate a short, medium and long-term service delivery model for SACT delivery on NHS Western Isles 2
3 Support the local development of a road-map to implement any of the agreed changes in service specification. This paper collates these discussions, and offers suggestions for a way forward that were shared in the final session. Background Service Provision The model of cancer care delivered to patients in NHS WI is a hub and spoke approach between Raigmore Cancer Centre (NHS Highland) and NHS Western Isles. A service level agreement exists to support this but was not available at the time of the review. The majority of SACT treatments are prescribed by Oncology and Haematology Consultants based in Raigmore Hospital. Day-case SACT services in NHS Western Isles are primarily provided from the chemotherapy unit attached to Specials Ward in the Western Isles Hospital, Stornoway. Patients requiring longer or more intensive treatment regimens are treated in Raigmore Hospital. Cancer patients requiring planned, supportive treatments, for example blood transfusions and bisphosphonates receive these in the Day Hospital, Western Isles Hospital. Patients in the Uists can receive day-case SACT therapy in Uist and Barra Hospital, Benbecula. Currently, most patients from NHS WI receiving treatment for gynaecological cancers are managed and treated at the Beatson Cancer Centre in the West of Scotland Cancer Area Network (WOSCAN). All cancer treatments for patients from Barra are provided by the Beatson Cancer Centre. This is due to the more straightforward transport links between the Island of Barra and Glasgow. Communication between the cancer teams in the Beatson and the WI about patients undergoing SACT is less than ideal, adversely affecting the ability of the islandbased team to support patients. A Consultant Oncologist based in Raigmore Hospital Cancer Centre visits the island once a month to review and manage his own patients and those of some of his colleagues at their request. Some patients are wholly managed by the clinicians from Raigmore, with direct communication between that patient s clinician and the NHS WI nursing and pharmacy staff for prescribing, checking and patient management purposes. This is a different model to that adopted by NHS Orkney, and NHS Shetland (comparable island Health Boards), who have no visiting consultant and it is unclear whether this model will be sustainable in the short or long term. The role of the visiting Consultant Oncologist is to: Assess new patients referred for Clinical Oncology opinion. Provide advice and information to patients about their disease and possible treatment options to enable them to make informed decisions and to obtain consent if appropriate to situation. Undertake review of some patients undergoing SACT treatments. Undertake review of patients with symptoms of their disease as requested. Follow-up of patients. The delivery of SACT to patients within the NHS WI has evolved over a number of years during which considerable experience has been gained. The service was initially based on 3
4 the Surgical Ward, staffed by nurses from the surgical ward, including a ward manager. The nurse-led SACT service was initially led by a Macmillan Chemotherapy Nurse. They have since left and the ward manager has retired. The service is provided and operationally managed within the Acute Hospital Service. The current surgical ward manager has no experience in SACT services but has operational responsibility for allocating nursing resource to it. The nursing resource allocated to the SACT service from the Surgical Ward is set at one whole time equivalent (WTE) Band 6 shared between two members of staff trained to administer Chemotherapy who are also part of the overall staffing complement of the surgical ward. The strategic and professional leadership of the SACT service is provided by the Macmillan Lead Cancer Nurse, Gill Chadwick, who is SACT trained. She has no operational or managerial accountability for the service. The Macmillan Lead Cancer Nurse is a member of the Macmillan Nursing Team The Macmillan Lead Cancer Nurse and another member of the Macmillan Team, also SACT trained, provide a significant degree of support to the SACT substantive post-holders covering, holiday periods, sickness, and training. Their input is necessary as no other members of the surgical ward nursing team are SACT trained, therefore, they do not have the required skills, training, experience or competencies necessary to provide the appropriate level of cover. The pre-treatment monitoring and support of patients undergoing SACT is provided by the SACT trained nurses who carry out a telephone assessment of patients on the day prior to planned treatment. Members of the Macmillan Team, not all of whom are chemotherapy trained, also monitor and support their own patients between cycles. The provision of this support is not defined and depends more on patient/staff communication relationships. Drivers for change There are currently a number of internal and external drivers that will impact on how the SACT service for NHS WI patients is managed and delivered. There is general recognition that patients and their families prefer treatment to be administered locally when this can be done safely. Patient demand for this service will see numbers increase. The recently published CEL 30 (2012) articulates the standards for safe delivery of SACT. When fully implemented these standards will assure the quality and safety of services provided at all sites. CEL compliance is a powerful driver in facilitating a more systematic approach in selecting patients for local treatments. The existing model of cancer care, led by a visiting oncologist may be compromised due to the imminent retiral of the key post holder (March 2014). This, combined with the recognised national shortage of oncology consultants is likely to result in medical staffing issues within the Department of Clinical Oncology, Raigmore Hospital. In the longer term, an ever expanding service sector will continue to challenge the sustainability of the existing service. On Island SACT services provided without a visiting oncologist are well established in NHS Orkney and NHS Shetland. It is of clear benefit to both NHS WI and its patients to carefully nurture the specialism, skills and experience available and consider changes in skill mix and service provision that would enhance local quality SACT services. 4
5 The adoption of a Chemotherapy Electronic Prescribing and Administration System (CEPAS) increases the ability for remote patient management by prescribing clinicians. It enables non-paper monitoring, real-time access to patient s treatment data and provides a patient-specific communication mechanism. All SACT treatment must be prescribed through this system to comply with the CEL standards. The repatriation of the travel budget to NHS Western Isles, for patients who continue to receive SACT treatment at Raigmore or Beatson Cancer Centres, offers a financial incentive to develop local services to minimise patient travel. Whilst it is recognised this will potentially offer significant savings for the local board, reallocation of some of the travel monies would be required to increase and improve the service, where travel to Raigmore Hospital and the Beatson Cancer Centre in Glasgow can be avoided. There is a different and more complex piece of work that will be required to be undertaken around the existing/historical service level agreements. A current national initiative looking into Transforming Care After Treatment TCAT (NHS Scotland & Macmillan Cancer Support 2013) jointly funded by Macmillan Cancer Support and the Scottish Government seeks to improve the quality of follow up and aftercare. This initiative could significantly improve the local delivery of care to patients surviving cancer. There have been recent improvements in the stability of pre-constituted chemotherapy agents, a number of which are commercially sourced in dose bands. This has enabled SACT agents to be given longer expiry dates, offering opportunities to safely transport SACT agents over extended timeframes. This increased flexibility in supply enables more chemotherapy to be sent to remote facilities. Dose Banding of SACT is an accepted and standardised practice across NHS Scotland. If SACT medicines are supplied and dispensed from the WI pharmacy, it is important for CEL compliance that a level of specialist expertise in cancer is further developed and provided by pharmacists on the Island. This would be possible with appropriate resource, time and contingency arrangements. This needs to be formally assessed through a skill mix review mechanism to ensure the resource is applied in an efficient manner. The level of input of the Macmillan team into the management of patients receiving SACT is having an adverse impact on their caseloads. If the Macmillan team was to continue to manage patients receiving SACT they would need to undertake specific SACT training to comply with the CEL. Government policy with respect to the Scottish Medicines Consortium (SMC) and the use of high cost medicines is inevitably going to lead to additional treatment options for patients and increased lines of therapy. Assessment of the current chemotherapy service The strengths of the current local service are as follows: There is an excellent level of commitment to providing a high quality SACT service on the Island from all staff. 5
6 The existing model of service delivery offers continuity of care through the cancer journey that is holistic. Often, the same nurse is with the patient at diagnosis, through all treatments and when needed during the palliative stage. This aspect of the service is beneficial for a small island board and as far as possible needs to be preserved. There is a commitment to collaborate in the delivery and care of patients receiving SACT between the cancer teams in NHS WI and NHS H - including medical, pharmacy and nursing staff. Most patients are assessed by a member of the nursing team prior to treatment (regardless of whether the chemotherapy is given in Western Isles or in Raigmore). This contributes to ensuring that the service for patients is safe (i.e. patients only get chemotherapy if their blood count and other parameters have been assessed) and minimises unnecessary patient travel. This significantly adds to the culture of patient safety and patient-centred care. Good co-operation between the pharmacy and nursing services on the island ensures the timeous supply of SACT treatments to the chemotherapy unit for patients receiving treatment on the Islands. The availability of Gaelic language speakers within the Islands SACT service is beneficial for cancer patients, many of whom use Gaelic as a first language. The benefit of not having to travel to receive chemotherapy is widely recognised and valued by patients receiving SACT treatment on the islands. The weaknesses of the current service are: The delivery of chemotherapy treatments on Western Isles is primarily dependent on 2 members of staff (1WTE). This is a concern in terms of providing adequate cover during annual leave and unplanned absences as this is currently provided by 2 members of the Macmillan Team who are SACT trained. If the cover arrangements are not managed appropriately, this can be the source of tension between the substantive post holders and the individuals required to cover. The current arrangements for service provision would have limited capacity to undertake the significant increase in workload anticipated from changes in government policy and the additional opportunity to repatriate further WI patients requiring SACT. Communication between Beatson Cancer Centre and the local cancer team is described as being very limited and unreliable; resulting in the local team being excluded and unable to adequately support patients at home. Initiatives placing additional demands on the SACT service providers, can have a negative impact on team working and cause friction. This is because it can falls between two possible services which have full commitments either to the Specials Ward or members of the Macmillan Team. Within this environment, opportunities exploring developing services can be viewed negatively rather than as an opportunity for service quality improvement. The direct operational management of the SACT treatment room by individuals without direct experience of SACT services may unintentionally, negatively impact on the quality of that service, which is highly specialist in nature with specific 6
7 governance standards that must be achieved to ensure the safe delivery of a locallybased SACT service. The leadership/management of SACT services on the island is compromised due to the split operation/professional management into separate service divisions. Providing a more united professional/operational leadership would improve the potential of the SACT service to meet and address the ever changing challenges to service provision. The criteria for patient selection for locally delivered SACT appears to be based on historical agreements and the personal choices of individual clinicians and/or Cancer Centres. There are clear inconsistencies in who is selected to have their treatment delivered in the Western Isles; these do not appear to be based on systematic descriptions of potential disease or treatment related clinical risks or patient safety concerns. Practically, this is resulting in similar SACT regimens being prescribed by one consultant to be given in the Western Isles but by another consultant, to be administered in one of the cancer centres. The recent chemotherapy IT system (CEPAS) is not being used to its full potential for managing patients on the Western Isles. Moreover it is currently not linked to the SCI store in the Western Isles. In Raigmore Hospital, there are 4 clinical oncologists who sub-specialise. Currently, the Clinical Oncologist visiting NHS WI reviews his own patients and those of his colleagues at their request. He also assesses new patients with breast cancer, referred to him by the breast MDT. In future, the availability of a single clinical oncologist willing to manage patients undergoing treatment for any cancer may be challenging and may not be the most appropriate way to manage patients receiving SACT. Currently electronic and paper based systems exist for the prescribing and administration of SACT treatment in NHS WI. The paper-based system has persisted due to problems encountered by the prescriber in accessing CEPAS from a desk-top computer in the Western Isles Hospital. This is a recognised as a significant risk in the service. The service currently has inbuilt inefficiencies due to hand written signatures being required for prescription dispensing and administration services using the CEPAS system. This is not necessary in a system that is password protected and can provide named indicators of allocator, checker and authorisation. It is recognised that this is a complex issue which needs to be addressed in partnership with the prescribing cancer centre. The pre-treatment assessment and follow up of patients on SACT appears to be shared between the Macmillan nurses (not all of whom are SACT trained), and the SACT nurses. Roles and role-definitions regarding these are unclear. It would appear that patients are sometimes reviewed between SACT cycles by their Macmillan Team. The Macmillan Team then report their findings back to the SACT nurses at a weekly meeting. The patients then appear to receive a further pre-treatment review the day before their treatment. The reviewers are of the opinion that a mid-cycle review is unnecessary and not standard practice elsewhere in Scotland. They also believe that the intervention mid-cycle by the Macmillan team can only act to confuse the patient as to who they should contact, and who will resolve any issues/toxicities related to their SACT. For a patient to receive the appropriate assessment and 7
8 follow-up of any toxicity, this needs to be done through direct contact with the SACT trained nurses. Non-SACT trained Macmillan Nurses are in some cases, assuming the responsibility for discussing patient toxicities and dose adjustments with clinicians in the cancer centres; bypassing the routine SACT trained chemotherapy givers and in essence relegating the role of those individuals to merely a technical operative. This brings with it further communication risks. The proposed Road Map General principles The proposed Road Map for sustaining and developing the current chemotherapy service in the Western Isles is predicated on the following principles: 1. All aspects of the delivery of SACT must be safe, and fully comply with CEL 30 (2012). 2. The principle for treatment being given safely as close to home as possible must apply, with the concept of safety taking precedence. 3. Policies and pathways must continue to be delivered as a shared care model, with treatment initiated, support and expert advice given from the cancer centres in Inverness and Glasgow. 4. Changes or increases in locally administered chemotherapy is best delivered at a evolutionary pace, that takes into account the need for workforce development and engagement of teams across the network. It must be sustainable; with a workforce that is appropriate to the skills required both assessing patients fitness/response to chemotherapy and for delivering chemotherapy treatments. 5. The service must be affordable in the context of a workforce that is appropriate to the levels of skills required to deliver the service. 6. Developments must be sensitive to the service configuration in NHS WI and must continue to support patients across a pathway from diagnosis to end of life. 7. Local SACT services must continue to be driven by positive patient experience in the context of what is achievable in a remote and rural setting. Recommendations and issues to consider Achieving a change in the design and provision of SACT services in NHS WI requires a number of areas to be addressed. These need to be distilled into an action plan, with ongoing communication and support to deliver this from NOSCAN, Raigmore Hospital Cancer Centre and to some extent, the Beatson Oncology Cancer Centre. Detailed work is required with the wider services in the cancer centres in Inverness and the Beatson Cancer Centre to identify and agree treatments which can be feasibly delivered in NHS WI. All aspects of the SACT service must be fully compliant with CEL 30 (2012) and not based on historical patterns of working from individual clinicians or Cancer Centres. 8
9 These services must be determined in line with the afore-mentioned governing principles. Bearing in mind the impending difficulties with oncology staffing, NHS WI would be advised to carefully consider how the follow-up of patients after cancer treatments could be achieved. The reviewers believe that if the Macmillan Nurses were relieved of some of the current roles they undertake for patients receiving SACT, there would be the potential for some of this valuable resource to be reassigned to this important work-stream. This would also match the current government agenda set out in the Transforming Care After Treatment TCAT initiative There was agreement amongst contributors that the provision of SACT would be improved by developing a service with its own distinct identity, separate to that of the surgical ward and Macmillan Nursing service. It is envisaged that this would have its own separate line of professional and operational leadership. This would improve the clarity in management and leadership accountability, service provision, and dispense with conflicting priorities amongst team members. It would improve role clarity and the job satisfaction for the team administering the SACT. The close communication links with the Macmillan Nursing team must be maintained to ensure the patients continue to benefit from the continuity of care provided by the cancer team. To ensure continuity of care, it is recommended that the Macmillan Team routinely refer patients highlighting treatment related issues to the SACT trained nurses for ongoing management and escalation as required. Sustaining a regular on Island SACT service would be best accomplished by highly skilled specialist nurses working to Advanced Nurse Practitioner Level (ANP) with skills to examine patients and prescribe and administer supportive therapies for patients. The grading issues required to attract, develop and maintain this level of competency would have to be carefully considered. As a minimum, the reviewers believe the on Island SACT service requires the equivalent of 2 WTE; this includes the additional resource already identified for contingency arrangements. We recommend that such arrangements are considered, evaluated, formalised and agreed. The provision of a pre- initial treatment review by the SACT nurses could improve the introduction of patients to the SACT service, ensure the patients are well informed, have consented to treatment and have all the important communication pathways in place and understood. It may also relieve some of the stress for patient when attending for their first treatment. On completion of treatment, a defined hand-over of the patient into their ongoing care team with an update of their status should occur. An open mind may be required to alternative models of delivery of care that would allow patients to have their bloods taken more locally, for example in GP Practices and for the extension of telephone pre-treatment assessment for patients living at a distance from the SACT units. The stability and delivery arrangements of some SACT agents may require increased flexibility with regard to treatment days. 9
10 The involvement of a pharmacist in addition to the pharmacy technician must be implemented if chemotherapy supplies from the Island pharmacy service to the SACT service is to comply with the CEL. For CEL compliance, further training is required within pharmacy, when these requirements are more clearly defined across Scotland. Additional resources are needed to release staff to undertake this work. A skill mix review may provide an efficient way of addressing the needs to release pharmacist staffing for the island service. Robust communication links with the prescribing cancer centres must be maintained. Contingency arrangements involving the Cancer Centres may need to be negotiated and established to maintain an efficient use of resource, for example, during the absence of the specialist SACT pharmacist. A clear understanding of the opportunity costs and savings that can be made by further expanding SACT and Cancer Services on the Island may provide a useful funding stream to enable the necessary service developments to be achieved. Opportunities for the ANPs and pharmacists to travel to the cancer centres for training and updates must be provided to enable them to maintain the essential competencies, learn new skills and develop close working relationships with the wider SACT team in the North. For a health board the size of the Western Isles, the reviewers would suggest that patients requiring SACT agents for non-cancer treatments and other disease modifying parenteral products should be centralised to the SACT team where the appropriate skill set is available. Threats to the development of a locally delivered chemotherapy The main threats to sustaining and developing the current service are: Inappropriate skill mix; the current model is not sustainable in a service that looks to maintain or further develop its capacity to deliver treatments locally. Resistance to a more patient centred treatment pathway from the Beatson Cancer Centre due to perceived safety concerns. Resistance to change from individual clinicians in both Raigmore and the Beatson Cancer Centres Lack of understanding from senior management on the island of the specialist nature and specific governance standards required in the process of delivering a locallybased chemotherapy service. Lack of finance and staffing to undertake the work outlined above. Conclusion A local service re-design is necessary to meet the short, medium and long term challenges in providing SACT services to patients on the islands. The key building blocks for a quality SACT service are available within NHS WI but need to be reconfigured to improve the transparency, consistency and ownership of the service. 10
11 All staff caring for cancer patients on the island are committed to providing a safe, effective, quality service locally. The provision of the existing SACT service confirms this. With careful planning, the SACT service could be expanded to benefit increased numbers of patients. The recent publication of the chemotherapy CEL 30 (2012) is a powerful driver to support the strengthening of the existing service and its ongoing expansion. In order to progress these developments, it is recommended that NHS WI develop an action plan with support from the regional cancer network (NOSCAN) and its partner Cancer Centres in Inverness and Glasgow. It is recommended that the action plan examines the short to medium-term delivery options for chemotherapy delivery within NHS WI and after considering the points raised in this document, undertake a redesign that encompasses the needs of patients, the workforce, service quality and the affordability dimensions of the service. It is our assessment that the service as it is currently configured, will struggle to provide for the needs of patients on the Western Isles as it confronts the new challenges ahead. Mark Parsons Macmillan Regional Pharmacist North of Scotland Cancer Advisory Group Fiona Campbell Macmillan CNS Oncology/Chemotherapy November 2013 References NHS Scotland & Macmillan Cancer Support (2013) Transforming Care after Cancer TCAT: National Launch Event 13 th June The Scottish Government (2012) [Revised] Guidance for the safe delivery of Systemic Anti- Cancer Therapy (SACT) CEL 30 (2012) 11
The role was given distinct workstreams, as agreed in partnership with Macmillan as part of the funding process. These workstreams included:
Item 5-14c Regional Cancer Pharmacist Role Summary The Macmillan Regional Lead Cancer Pharmacist role was initiated at the beginning of June 2011 for a three year period, funded by Macmillan Cancer Relief
More informationSystemic Anti-Cancer Therapy Delivery. June 2017 National External Review
Systemic Anti-Cancer Therapy Delivery June 2017 National External Review Healthcare Improvement Scotland is committed to equality. We have assessed the review process for likely impact on equality protected
More informationOPTIONS APPRAISAL PAPER FOR DEVELOPING A SUSTAINABLE AND EFFECTIVE ORTHOPAEDIC SERVICE IN NHS WESTERN ISLES
Highland NHS Board 9 August 2011 Item 4.3 OPTIONS APPRAISAL PAPER FOR DEVELOPING A SUSTAINABLE AND EFFECTIVE ORTHOPAEDIC SERVICE IN NHS WESTERN ISLES Report by Sheila Cascarino, Divisional Manager, Surgical
More informationNorth of Scotland Quality and Governance Framework for Cancer
North of Scotland Quality and Governance Framework for Cancer Aim There has been two significant guidance and direction given by the Scottish Government Health Department in respect to the delivery and
More informationNHS Grampian. Intensive Psychiatric Care Units
NHS Grampian Intensive Psychiatric Care Units Service Profile Exercise ~ November 2009 NHS Quality Improvement Scotland (NHS QIS) is committed to equality and diversity. We have assessed the performance
More informationORAL ANTI-CANCER THERAPY POLICY
ORAL ANTI-CANCER THERAPY POLICY Document Author Written By: Lead Oncology Pharmacist Authorised Authorised By: Chief Executive Officer Date: vember 2016 Date: 11 th April 2017 Lead Director: Executive
More informationAdministration of Intrathecal Cytotoxic Chemotherapy in NHS Grampian
Administration of Intrathecal Cytotoxic Chemotherapy in NHS Grampian Lead Author/Coordinator: Jeff Horn / Sarah Howlett Macmillan Haematology CNS/ Pharmacist Reviewer: Gavin Preston Consultant Haematologist
More informationYvonne Blucher, Managing Director Southend University Hospital. Michael Catling, Cancer Programme Director MSB
Meeting Title Mid and South Essex Acute Trusts Joint Working Board (meeting in public) Meeting Date 18 th October 2017 Agenda No 10 Report Title Oncology Service Report Lead Executive Director Report Author
More informationNHS Highland Plan for rebalancing of Primary Care Dental Services
Highland NHS Board 3 February 2015 Item 4.3 NHS Highland Plan for rebalancing of Primary Care Dental Services 2015-2020 Report by Dr Ken Proctor Associate Medical Director, Executive Director for Primary
More informationMutual Aid between North Of Scotland Health Boards
Meeting: NoSPG Date: 16 th March 2016 Item: 13/16 NORTH OF SCOTLAND PLANNING GROUP Mutual Aid between North Of Scotland Health Boards NoSPG is asked to: To review and reflect on the content of the enclosed
More informationFULL TEAM AHEAD: UNDERSTANDING THE UK NON-SURGICAL CANCER TREATMENTS WORKFORCE
FULL TEAM AHEAD: UNDERSTANDING THE UK NON-SURGICAL CANCER TREATMENTS WORKFORCE DECEMBER 2017 Publication date 04/12/17 Registered Charity in England and Wales (1089464), Scotland (SC041666) and the Isle
More informationBriefing on Shaping Our Future urgent care work stream progress
Briefing on Shaping Our Future urgent care work stream progress 1. Purpose The purpose of this paper is to describe, update and clarify on the Cornwall and the Isles of Scilly s Shaping Our Future urgent
More informationSeptember Workforce pressures in the NHS
September 2017 Workforce pressures in the NHS 2 Contents Foreword 3 Introduction and methodology 5 What professionals told us 6 The biggest workforce issues 7 The impact on professionals and people with
More informationPEER REVIEW VISIT REPORT (MULTI-DISCIPLINARY TEAM)
PEER REVIEW VISIT REPORT (MULTI-DISCIPLINARY TEAM) Network Organisation Team YHSCN HULL AND EAST YORKSHIRE HOSPITALS Hull And East Yorkshire Hospitals Haematology MDT (13-2H-1) - 2015 Peer Review Visit
More informationUrology Clinical Forum. 11 th March 2015
Urology Clinical Forum 11 th March 2015 Welcome and Introductions Justin Vale, Chair of the LCA Urology Pathway Group Progress of the Urology Pathway Group Justin Vale, Chair of the LCA Urology Pathway
More informationPrimary Care Workforce Survey 2013
Experimental Report Primary Care Workforce Survey 2013 Out of Hours GP Services Strand Sections 1,2,3 and 6 Publication Date 19 November 2013 Contents Introduction... 2 Method of completing the survey...
More informationLIVING & DYING WELL AN ACTION PLAN FOR PALLIATIVE AND END OF LIFE CARE IN HIGHLAND PROGRESS REPORT
Highland NHS Board 4 October 2011 Item 5.3 LIVING & DYING WELL AN ACTION PLAN FOR PALLIATIVE AND END OF LIFE CARE IN HIGHLAND PROGRESS REPORT Report by Chrissie Lane, Cancer Nurse Consultant/Project Lead
More informationThe PCT Guide to Applying the 10 High Impact Changes
The PCT Guide to Applying the 10 High Impact Changes This Guide has been produced by the NHS Modernisation Agency. For further information on the Agency or the 10 High Impact Changes please visit www.modern.nhs.uk
More informationabcdefghijklmnopqrstu
Directorate for Chief Medical Officer, Public Health and Sport Sir Harry Burns, MPH FRCS (Glas) FRCP(Ed) FFPH Health and Social Care Directorate Pharmacy and Medicines Division Professor Bill Scott, MSc,
More informationPrimary Care Workforce Survey Scotland 2017
Primary Care Workforce Survey Scotland 2017 A Survey of Scottish General Practices and General Practice Out of Hours Services Publication date 06 March 2018 An Official Statistics publication for Scotland
More informationManaging Nurse Led Chemotherapy Pre- Assessment Guidelines
Network Guidance Document Managing Nurse Led Chemotherapy Pre- Assessment Guidelines Status: Review Date: Version Number: Publication Date: Published March 2010 1.0 June 2008 Agenda Number: 5A Attachment
More informationOur community nursing roles
Our community nursing roles Community Nursing Services provide nursing care to house-bound patients within the community. Our aim is to help patients to remain healthy and independent for as long as possible,
More informationNORTH OF SCOTLAND PLANNING GROUP
NORTH OF SCOTLAND PLANNING GROUP Minute of virtual meeting held on Wednesday 18 th April 2012 at 10.30am NORTH OF SCOTLAND PLANNING GROUP Present: Aberdeen: In attendance: Dundee: In attendance: Inverness:
More informationDRAFT. Rehabilitation and Enablement Services Redesign
DRAFT Rehabilitation and Enablement Services Redesign Services Vision Statement Inverclyde CHP is committed to deliver Adult rehabilitation services that are easily accessible, individually tailored to
More informationADVANCED NURSE PRACTITIONER STRATEGY
ADVANCED NURSE PRACTITIONER STRATEGY 2016-2020 Lead Manager: Chair, GG&C Advanced Practice Group Responsible Director: Board Nurse Director Approved by: NMAHP Group Date approved Date for review: September
More informationMDT Peer Review Report Proforma
Network Trust NICaN Western Health and Social Care Trust Lung MDT Visit Date 13 September 2017 Structure and function of the service The Western Health and Social Care Trust (WHSCT) was established on
More informationIntensive Psychiatric Care Units
NHS Highland Argyll & Bute Hospital, Lochgilphead Intensive Psychiatric Care Units Service Profile Exercise ~ November 2009 NHS Quality Improvement Scotland (NHS QIS) is committed to equality and diversity.
More informationNHS GRAMPIAN. Grampian Clinical Strategy - Planned Care
NHS GRAMPIAN Grampian Clinical Strategy - Planned Care Board Meeting 03/08/17 Open Session Item 8 1. Actions Recommended In October 2016 the Grampian NHS Board approved the Grampian Clinical Strategy which
More informationA census of cancer, palliative and chemotherapy speciality nurses and support workers in England in 2017
A census of cancer, palliative and chemotherapy speciality nurses and support workers in England in 2017 2 Contents Contents Foreword 2 Executive Summary 4 Background and Methodology 6 Headline findings
More informationIntegration Scheme. Between. Glasgow City Council. and. NHS Greater Glasgow and Clyde
Integration Scheme Between Glasgow City Council and NHS Greater Glasgow and Clyde December 2015 Page 1 of 60 1. Introduction 1.1 The Public Bodies (Joint Working) (Scotland) Act 2014 (the Act) requires
More informationIntensive Psychiatric Care Units
NHS Lothian St John s Hospital, Livingston Intensive Psychiatric Care Units Service Profile Exercise ~ November 2009 NHS Quality Improvement Scotland (NHS QIS) is committed to equality and diversity. We
More informationJOB DESCRIPTION. Pharmacy Technician
JOB DESCRIPTION Pharmacy Technician Issued by AT Medics Primary Care Pharmacy Technician Job Description Job Title: Reporting to: Location: Salary: Job status: Contract: Notice Period: Primary care pharmacy
More informationPrimary Health Networks
Primary Health Networks Drug and Alcohol Treatment Activity Work Plan 2016-17 to 2018-19 Western Victoria PHN When submitting this Activity Work Plan 2016-2018 to the Department of Health, the PHN must
More informationIntegrated Health and Care in Ipswich and East Suffolk and West Suffolk. Service Model Version 1.0
Integrated Health and Care in Ipswich and East Suffolk and West Suffolk Service Model Version 1.0 This document describes an integrated health and care service model and system for Ipswich and East and
More informationNHS HDL (2002) 22 abcdefghijklm
NHS HDL (2002) 22 abcdefghijklm Health Department Dear Colleague SAFE ADMINISTRATION OF INTRATHECAL CYTOTOXIC CHEMOTHERAPY Purpose This circular provides Guidance on the Safe Administration of Intrathecal
More informationScottish Ambulance Service. Our Future Strategy. Discussion with partners
Discussion with partners Our values Glossary of terms We will: put the patient at the heart of everything we do. treat each and every person well, with respect and dignity. always be open, honest and fair.
More informationJob Description. Job title: Gynae-Oncology Clinical Nurse Specialist Band: 7. Department: Cancer Services Hours: 30
Job Description Job title: Gynae-Oncology Clinical Nurse Specialist Band: 7 Department: Cancer Services Hours: 30 Reports to: Lead Nurse for Cancer We are a pioneering research active organisation and
More informationTOPIC 9 - THE SPECIALIST PALLIATIVE CARE TEAM (MDT)
TOPIC 9 - THE SPECIALIST PALLIATIVE CARE TEAM (MDT) Introduction The National Institute for Clinical Excellence has developed Guidance on Supportive and Palliative Care for patients with cancer. The standards
More informationAllied Health Review Background Paper 19 June 2014
Allied Health Review Background Paper 19 June 2014 Background Mater Health Services (Mater) is experiencing significant change with the move of publicly funded paediatric services from Mater Children s
More informationTitle: Climate-HIV Case Study. Author: Keith Roberts
Title: Climate-HIV Case Study Author: Keith Roberts The Project CareSolutions Climate HIV is a specialised electronic patient record (EPR) system for HIV medicine. Designed by clinicians for clinicians
More informationJOB DESCRIPTION. Lead Haematology/Chemotherapy Clinical Nurse Specialist Head of Nursing Medicine
JOB DESCRIPTION Job Title: Department: Medicine - Haematology Day Care Unit Reports to: Lead Haematology/Chemotherapy Clinical Nurse Specialist Head of Nursing Medicine Liaises with: Lead Haematology/Chemotherapy
More informationWorkforce Planning & Redesign
WORKFORCE PLAN 2017-2020 Author Service Lead and Queries Executive Lead Pauline Rae Gerry Lawrie Dr Annie Ingram Workforce Planning & Redesign 1 P a g e Do you have a visual impairment or have difficulty
More informationAyrshire and Arran NHS Board
Paper 12 Ayrshire and Arran NHS Board Monday 30 January 2017 Medical Education and Training: Update on Enhanced monitoring status of University Hospital Ayr Medical Department Author: Hugh Neill, Director
More informationScottish Medicines Consortium. A Guide for Patient Group Partners
Scottish Medicines Consortium Advising on new medicines for Scotland www.scottishmedicines.org page 1 Acknowledgements Some of the information in this booklet is adapted from guidance produced by the HTAi
More informationabcdefghijklmnopqrstu
Health Directorates Healthcare Planning and Policy Dear Colleague SAFE ADMINISTRATION OF INTRATHECAL CYTOTOXIC CHEMOTHERAPY Purpose This circular provides revised guidance on the Safe Administration of
More informationSCOTTISH AMBULANCE SERVICE JOB DESCRIPTION
SCOTTISH AMBULANCE SERVICE JOB DESCRIPTION Job Title: Reporting To: Department(s)/Location: Consultant Paramedic OHCA Programme Lead Medical Director Medical Directorate Job Reference number (coded): Background
More informationJob Description. Job title: Uro-Oncology Clinical Nurse Specialist Band: 7
Job Description Job title: Uro-Oncology Clinical Nurse Specialist Band: 7 Department: Cancer Services Hours: 37.5 (min 22.5 hrs) Reports to: Lead Nurse for Cancer We are a pioneering research active organisation
More informationPost Title Consultant in Palliative Medicine Inpatient Unit and Great Western Hospital
Job Description Post Title Consultant in Palliative Medicine Inpatient Unit and Great Western Hospital Salary: Tenure: Reporting to: 76, 761-103, 490 pa pro-rata, according to level of experience Substantive.
More informationUKMi PDS Tuesday 27 th September 2016
Implications of the Carter report for MI, what we can learn from colleagues in Scotland? Yvonne Semple Lead Pharmacist, MI Services NHS GGC UKMi PDS Tuesday 27 th September 2016 What can we learn from
More informationTransforming Cancer Services In South East Wales
Transforming Cancer Services In South East Wales Clinical Service Model January 2016 Cancer survival rates are increasing. But the number of people getting cancer is increasing too. At Velindre NHS Trust
More informationPCA (P) (2016) 1. Background
Healthcare Quality and Strategy Directorate Pharmacy and Medicines Division Dear Colleague STOMA APPLIANCE SERVICE IN THE COMMUNITY PUBLICATION OF STOMA CARE QUALITY AND COST EFFECTIVENESS REVIEW REPORT
More informationHealth and Care Framework
Annex 1 Health and Care Framework The NHS Grampian 2020 A Possible Future 1. NHS Grampian has agreed its Health Plan and has embarked on its Health and Care Framework (H&CF) process to determine in detail
More informationExecutive Summary / Recommendations
Learning Disability Change Programme A Strategy for the Future Proposed Service Specification for Adult Learning Disability Services in Greater Glasgow & Clyde Executive Summary / Recommendations 1 1.
More informationCA1 Enhanced Supportive Care for Advanced Cancer Patients
CA1 Enhanced Supportive Care for Advanced Cancer Patients Scheme Name QIPP Reference Eligible Providers CA1 Enhanced Supportive Care (ESC) Access for Advanced Cancer Patients QIPP 16-17 S23- Cancer Cancer
More informationContents. Appendices References... 15
March 2017 Pharmacists Defence Association Response to the General Pharmaceutical Council s Consultation on Initial Education and Training Standards for Pharmacy Technicians representing your interests
More informationGOVERNING BODY MEETING in Public 27 September 2017 Agenda Item 5.2
GOVERNING BODY MEETING in Public 27 September 2017 Paper Title Report Author Neil Evans Turnaround Director Referral Management s Contributors John Griffiths Date report submitted 20 September 2017 Dean
More informationSummary Job Description Nurse Practitioner
Summary Job Description Nurse Practitioner Managing Partner Jo Gilford Senior Partner - Dr Gareth James Clinical Lead Dr Amy Butler Danetre Medical Practice 28/11/2017 Date: November 2017 We are recruiting
More informationJob Description. CNS Clinical Lead
Job Description CNS Clinical Lead POST: BASE: ACCOUNTABLE TO: REPORTS TO: RESPONSIBLE FOR: CNS Clinical Lead St John s Hospice Head of Nursing and Quality Head of Nursing and Quality Community Clinical
More informationSystemic anti-cancer therapy Care Pathway
Network Guidance Document Status: Expiry Date: Version Number: Publication Date: Final July 2013 V2 July 2011 Page 1 of 9 Contents Contents... 2 STANDARDS FOR PREPARATION AND PHARMACY... 3 1.1 Facilities
More informationNHS community pharmacy advanced services Briefing for GP practices
NHS community pharmacy advanced services Briefing for GP practices August 2013 This document has been developed jointly by NHS Employers, the Pharmaceutical Services Negotiating Committee (PSNC) and the
More informationSeven day hospital services: case study. South Warwickshire NHS Foundation Trust
Seven day hospital services: case study South Warwickshire NHS Foundation Trust March 2018 We support providers to give patients safe, high quality, compassionate care within local health systems that
More informationDraft Budget Royal College of Nursing Scotland
Background Draft Budget 2018-19 Royal College of Nursing Scotland At a time when budgets and resources are stretched, and ever increasing demands are being placed upon Scotland s health and social care
More informationShetland NHS Board. Board Paper 2017/28
Board Paper 2017/28 Shetland NHS Board Meeting: Paper Title: Shetland NHS Board Capacity and resilience planning - managing safe and effective care across hospital and community services Date: 11 th June
More informationThe TTO Journey: How Much Of It Is Actually In Pharmacy?
The TTO Journey: How Much Of It Is Actually In Pharmacy? Green CF 1,2, Hunter L 1, Jones L 1, Morris K 1. 1. Pharmacy Department, Countess of Chester Hospital NHS Foundation Trust. 2. School of Pharmacy
More informationWelsh Government Response to the Report of the National Assembly for Wales Public Accounts Committee Report on Unscheduled Care: Committee Report
Welsh Government Response to the Report of the National Assembly for Wales Public Accounts Committee Report on Unscheduled Care: Committee Report We welcome the findings of the report and offer the following
More informationCLINICAL STRATEGY IMPLEMENTATION - HEALTH IN YOUR HANDS
CLINICAL STRATEGY IMPLEMENTATION - HEALTH IN YOUR HANDS Background People across the UK are living longer and life expectancy in the Borders is the longest in Scotland. The fact of having an increasing
More informationApplication Pack: Applicants for Transformation Manager
Application Pack: Applicants for Transformation Manager Contents 1.0 Information about NHS Eastern Cheshire Clinical Commissioning Group and the Eastern Cheshire Healthcare Economy 2.0 Job Description
More informationPrimary Care Prescribing Cardiff and Vale University Health Board. Issued: December 2013 Document reference: 447A2013
Primary Care Prescribing Cardiff and Vale University Health Board Issued: December 2013 Document reference: 447A2013 Status of report This document has been prepared for the internal use of Cardiff and
More informationEQuIPNational Survey Planning Tool NSQHSS and EQuIP Actions 4.
Standard 1: Governance for safety and Quality and Standard 2: Partnering with Consumers Section 1 Governance, Policies, Business decision making, Organisational / Strategic planning, Consumer involvement
More informationFULL CONSULTATION DOCUMENT Proposed changes to the way Mental Health Services are delivered in the Western Isles
FULL CONSULTATION DOCUMENT Proposed changes to the way Mental Health Services are delivered in the Western Isles Your chance to comment on proposals This document provides full information about the consultation
More informationCollaborative Commissioning in NHS Tayside
Collaborative Commissioning in NHS Tayside 1 CONTEXT 1.1 National Context Delivering for Health was the Minister for Health and Community Care s response to A National Framework for Service Change in the
More informationChild and Adolescent Mental Health Services Waiting Times in NHSScotland
Publication Report Child and Adolescent Mental Health Services Waiting Times in NHSScotland Quarter ending 30 September 2017 Publication date 12 December 2017 A National Statistics Publication for Scotland
More informationTransforming NHS ambulance services
REPORT BY THE COMPTROLLER AND AUDITOR GENERAL HC 1086 SESSION 2010 2012 10 JUNE 2011 Department of Health Transforming NHS ambulance services 4 Summary Transforming NHS ambulance services Summary 1 In
More informationTHE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST COUNCIL OF GOVERNORS NATIONAL CANCER PATIENT EXPERIENCE SURVEY 2014
Agenda item 7(v) THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST COUNCIL OF GOVERNORS NATIONAL CANCER PATIENT EXPERIENCE SURVEY 2014 1. INTRODUCTION AND OVERVIEW The Cancer Patient Experience Survey
More informationEvaluation of Healthcare Service Provision on the Isle of Lismore
The University of Aberdeen and University of the Highlands and Islands working in partnership Evaluation of Healthcare Service Provision on the Isle of Lismore Final Report - Executive Summary January
More informationCatherine Hughson Kathryn Kearney Number of supervisors relinquishing role since last report:
Name of Local Supervising Authority: Western Isles Health Board Period of report: 2005/2006 Date: September 2006 1. Supervision of Midwives and Midwifery Practice 1.1 Designated Local Supervising Authority
More informationSCOTTISH DRIVING ASSESSMENT SERVICE: DRAFT FOR DOP COMMENT
Meeting: IPG Date: 20 th November 2013 Item: 54/13 NHS LOTHIAN National Chief Executives Group December 2013 Alex McMahon Director of Strategic Planning, Performance Reporting & Information Catriona Renfrew
More informationA Maternity Network for Wales
A Maternity Network for Wales Scoping Paper July 2013 Introduction This scoping exercise arises from a recommendation made in the Health and Social Care Committee s report One-day Inquiry into Stillbirth
More informationNursing and Midwifery Rostering. Policy. Asst. Director of Nursing, Workforce Planning. & Modernisation. Directorate of Primary Care and Older.
Policy Title Nursing and Midwifery Rostering Policy Policy Reference Number PrimCare11/01 Implementation Date January 2011 Review Date January 2013 Responsible Officer Asst. Director of Nursing, Workforce
More informationVisit to Hull & East Yorkshire Hospitals NHS Trust
Yorkshire and the Humber regional review 2014 15 Visit to Hull & East Yorkshire Hospitals NHS Trust This visit is part of a regional review and uses a risk-based approach. For more information on this
More informationConsultant Radiographers Education and CPD 2013
Consultant Radiographers Education and CPD 2013 Consultant Radiographers Education and Continuing Professional Development Background Although consultant radiographer posts are relatively new to the National
More informationNHS GRAMPIAN. Local Delivery Plan (LDP) 2016/17 Progress Report on Primary Care Chapter
NHS GRAMPIAN Board Meeting 06.04.17 Open Session Item 8 Local Delivery Plan (LDP) 2016/17 Progress Report on Primary Care Chapter 1. Actions Recommended The Board is asked to: Note and endorse the progress
More informationInitial education and training of pharmacy technicians: draft evidence framework
Initial education and training of pharmacy technicians: draft evidence framework October 2017 About this document This document should be read alongside the standards for the initial education and training
More informationIf you have not heard from us within a month of the closing date you should presume that you have not been shortlisted.
5 th December 2014 JOB VACANCY BULLETIN Locala Community Partnerships are committed to safeguarding and promoting the welfare of children, young people and vulnerable adults and expects all colleagues
More informationMain body of report Integrating health and care services in Norfolk and Waveney
Item 18.73a ii Norfolk and Waveney Sustainability and Transformation Plan Update for governing bodies and trust boards September 2018 Purpose of report The purpose of this paper is to update members of
More informationLIBERATING THE NHS: COMMISSIONING FOR PATIENTS. The Royal College of Obstetricians and Gynaecologists:
Direct telephone: +44 (0) 20 7772 6369 Direct facsimile: +44 (0) 20 7772 6232 Email: cdhillon@rcog.org.uk 8 October 2010 LIBERATING THE NHS: COMMISSIONING FOR PATIENTS Key Points The Royal College of Obstetricians
More informationPEER REVIEW VISIT REPORT (MULTI-DISCIPLINARY TEAM)
PEER REVIEW VISIT REPORT (MULTI-DISCIPLINARY TEAM) Network Organisation (Trust) Team MVCN LUTON AND DUNSTABLE Luton & Dunstable Colorectal MDT (11-2D-1) - 2011/12 Peer Review Visit Date 11th November 2011
More informationRedesign of Front Door
Redesign of Front Door Transforming Acute and Urgent Care Strategic Background and Context Our Change and Improvement Programme What have we achieved and how? What did we learn? Ian Aitken, General Manager
More informationSeven day hospital services: case study. University Hospital Southampton NHS Foundation Trust
Seven day hospital services: case study University Hospital Southampton NHS Foundation Trust March 2018 We support providers to give patients safe, high quality, compassionate care within local health
More informationSCOTTISH BORDERS HEALTH & SOCIAL CARE INTEGRATED JOINT BOARD UPDATE ON THE DRAFT COMMISSIONING & IMPLEMENTATION PLAN
Appendix-2016-59 Borders NHS Board SCOTTISH BORDERS HEALTH & SOCIAL CARE INTEGRATED JOINT BOARD UPDATE ON THE DRAFT COMMISSIONING & IMPLEMENTATION PLAN Aim To bring to the Board s attention the Scottish
More informationabcdefghijklmnopqrstu
Health Workforce Directorate Health Workforce Planning and Development Dear Colleague SUPPLEMENTARY MEDICAL STAFFING GUIDANCE TO BOARDS Purpose 1. This guidance sets out the best practice framework for
More informationWorking with you to make Highland the healthy place to be
HIGHLAND NHS BOARD Assynt House Beechwood Park Inverness IV2 3HG Tel: 01463 717123 Fax: 01463 235189 Textphone users can contact us via Typetalk: Tel 0800 959598 www.nhshighland.scot.nhs.uk Highland NHS
More informationNURSING & MIDWIFERY WORKLOAD & WORKFORCE PLANNING PROJECT RECOMMENDATIONS AND ACTION PLAN NOVEMBER 2006 UPDATE
Forma cm NHS HIGHLAND WORKLOAD AND WORKFORCE PLANNING PROJECT RECOMMENDATIONS AND ACTION PLAN NURSING & MIDWIFERY WORKLOAD & WORKFORCE PLANNING PROJECT RECOMMENDATIONS AND ACTION PLAN NHS HIGHLAND NOVEMBER
More informationPrimary Care Strategy. Draft for Consultation November 2016
Primary Care Strategy Draft for Consultation November 2016 1 Introduction Welcome to the Isle of Wight CCG s draft Primary Care Strategy. The CCG is required to develop and publish a strategy that sets
More informationSpecialised Services Commissioning Policy: CP160 Specialised Paediatric Neurological Rehabilitation
Specialised Services Commissioning Policy: CP160 Specialised Paediatric Neurological Rehabilitation April 2018 Version 4.0 Document information Document purpose Document name Author Policy Specialised
More informationChild and Adolescent Mental Health Services Waiting Times in NHSScotland
Publication Report Child and Adolescent Mental Health Services Waiting Times in NHSScotland Quarter ending 30 September 2016 Publication date 6 December 2016 An Official Statistics Publication for Scotland
More informationGuidance for consultants working in a system under pressure
Guidance for consultants working in a system under pressure (March 2018) British Medical Association bma.org.uk British Medical Association Guidance for consultants working in a system under pressure 1
More informationabcdefghijklmnopqrstu
Healthcare Policy and Strategy Directorate Quality Division Dear Colleague INTRODUCTION AND AVAILABILITY OF NEWLY LICENSED MEDICINES IN THE NHS IN SCOTLAND Dear Colleague This guidance sets out the policy
More informationPharmacy Medicine Use Review What s it all about?
Pharmacy Medicine Use Review What s it all about? 1. What is it? 1.1 Medicine use Review has been introduced under the Advanced Services tier of the New Pharmacy Contract in England & Wales. The aim of
More informationSafeguarding Vulnerable People Annual Report
Safeguarding Vulnerable People Annual Report 2014-2015 1. Purpose of report The purpose of this report is to provide assurance that the Trust is fulfilling its responsibilities to promote the safety and
More information